REGENXBIO develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector. read more
Sherri Everen ā Vice President, Ophthalmology Clinical Development at REGENXBIO
Executive Bio
Sherri Everen serves as the Vice President, Ophthalmology Clinical Development of REGENXBIO Inc.. Sherri started at REGENXBIO Inc. in November of 2018. Sherri currently resides in the San Francisco Bay Area.
Executive Team Culture Ratings from REGENXBIO Employees
BOTTOM
25%
REGENXBIO's Executive Team scores in the Bottom 25%
of similar sized companies on Comparably
of similar sized companies on Comparably
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at REGENXBIONot Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at REGENXBIOREGENXBIO's Executive Team at a Glance
Based on 10 ratings, REGENXBIO's employees are less satisfied with their Executive Team and give them a āD+ā or 61/100.
REGENXBIO's Executive Team ranks in the Bottom 30% of other companies in Washington, DC and Bottom 25% of other companies on Comparably that also have 1-10 Employees.
×